# Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA

> **NCT05079035** · PHASE2 · COMPLETED · sponsor: **BioTissue Holdings, Inc** · enrollment: 90 (actual)

## Conditions studied

- Knee Osteoarthritis
- Knee Pain Chronic
- Knee Arthritis

## Interventions

- **BIOLOGICAL:** TTAX03
- **BIOLOGICAL:** Saline

## Key facts

- **NCT ID:** NCT05079035
- **Lead sponsor:** BioTissue Holdings, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-06
- **Primary completion:** 2025-03-07
- **Final completion:** 2025-03-07
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05079035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05079035, "Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05079035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*